CASP3 and myocardial infarction: To identify the pro-survival effect of L-AZM therapies on cardiac cells post-MI, we assessed apoptosis in the peri-infarct region 3 days post-MI using caspase-3 (early apoptosis) and TUNEL (late apoptosis) staining.